Antiphospholipid syndrome primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Antiphospholipid syndrome}} {{CMG}} {{AE}} ==Overview== ==Primary Prevention== ==References== {{reflist|2}} Category:Disease Category:Rheumatology C...") |
|||
| Line 6: | Line 6: | ||
==Primary Prevention== | ==Primary Prevention== | ||
[[Randomized controlled trial]]s have addressed the secondary prevention of thromboses. These trials include APLASA<ref name="pmid17599766">{{cite journal| author=Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L et al.| title=Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. | journal=Arthritis Rheum | year= 2007 | volume= 56 | issue= 7 | pages= 2382-91 | pmid=17599766 | doi=10.1002/art.22663 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17599766 }} </ref>, | |||
==References== | ==References== | ||
Revision as of 02:51, 27 April 2017
|
Antiphospholipid syndrome Microchapters |
|
Differentiating Antiphospholipid syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Antiphospholipid syndrome primary prevention On the Web |
|
American Roentgen Ray Society Images of Antiphospholipid syndrome primary prevention |
|
Risk calculators and risk factors for Antiphospholipid syndrome primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Primary Prevention
Randomized controlled trials have addressed the secondary prevention of thromboses. These trials include APLASA[1],
References
- ↑ Erkan D, Harrison MJ, Levy R, Peterson M, Petri M, Sammaritano L; et al. (2007). "Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals". Arthritis Rheum. 56 (7): 2382–91. doi:10.1002/art.22663. PMID 17599766.